Chuncheon Sacred Heart Hospital
Clinical trials sponsored by Chuncheon Sacred Heart Hospital, explained in plain language.
-
Probiotics show promise for fatty liver in early trial
Disease control CompletedThis study tested whether three types of probiotics (Lactobacillus and Pediococcus strains) can improve liver health in people with non-alcoholic fatty liver disease. 89 adults took either a probiotic or a placebo daily for 8 weeks, along with a standard liver medication. Researc…
Phase: PHASE1, PHASE2 • Sponsor: Chuncheon Sacred Heart Hospital • Aim: Disease control
Last updated May 26, 2026 11:08 UTC
-
Probiotic shows promise for fatty liver in early trial
Disease control CompletedThis study tested whether a probiotic called L. lactis CKDB001 can improve liver health in people with nonalcoholic fatty liver disease (NAFLD). About 95 adults with mildly elevated liver enzymes took the probiotic or a placebo for 12 weeks. The main goal was to see if the probio…
Phase: NA • Sponsor: Chuncheon Sacred Heart Hospital • Aim: Disease control
Last updated May 01, 2026 15:58 UTC